Breakdown | |||
TTM | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Income Statement | Total Revenue | ||
10.43B | 9.47B | 8.96B | 8.09B | Gross Profit |
3.78B | 3.21B | 3.02B | 2.64B | EBIT |
1.37B | 1.27B | 1.25B | 856.73M | EBITDA |
1.61B | 1.56B | 1.53B | 1.14B | Net Income Common Stockholders |
1.02B | 847.46M | 830.93M | 545.37M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||
2.95B | 1.45B | 1.64B | 1.24B | Total Assets |
13.79B | 10.06B | 9.96B | 8.93B | Total Debt |
5.40B | 3.66B | 3.72B | 4.15B | Net Debt |
2.45B | 2.21B | 2.08B | 2.90B | Total Liabilities |
9.59B | 6.26B | 6.51B | 6.21B | Stockholders Equity |
4.20B | 3.80B | 3.45B | 2.72B |
Cash Flow | Free Cash Flow | ||
0.00 | 410.38M | 924.12M | 844.03M | Operating Cash Flow |
0.00 | 576.37M | 1.03B | 1.02B | Investing Cash Flow |
0.00 | 223.08M | -104.40M | -260.95M | Financing Cash Flow |
0.00 | -987.67M | -530.06M | -528.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥13.41B | 10.54 | 3.49% | -6.96% | -1.73% | ||
78 Outperform | ¥13.96B | 12.39 | 2.39% | 16.80% | 29.50% | ||
75 Outperform | ¥13.22B | 13.71 | 3.05% | 25.64% | ― | ||
73 Outperform | ¥12.89B | 22.16 | 3.15% | 6.14% | 4.14% | ||
66 Neutral | $4.51B | 12.22 | 5.40% | 3.63% | 4.14% | -12.01% | |
65 Neutral | ¥12.97B | 17.16 | 1.91% | 25.48% | ― | ||
58 Neutral | ¥12.68B | ― | 5.66% | -6.30% | 34.61% |